Godolphin, the international racing and breeding operation of Sheikh Mohammed bin Rashid al Maktoum, honored seven employees of U.S. trainers, racetracks, and farms on Friday as winners of its Thoroughbred Industry Employee Awards.
The U.S. government plans to issue an additional 64,000 H-2B visas this fiscal year to qualifying employers, the Department of Labor and Department of Homeland Security announced on Wednesday, vastly expanding a program that is heavily relied on by trainers.
The New York Racing Association on Wednesday announced the appointment of Andrew Offerman as vice president and general manager of operations of its three facilities -- Aqueduct, Belmont Park, and Saratoga.
The Horseracing Integrity and Safety Authority has hired Dr. James Hester, an orthopedic surgeon, to be its national medical director, focusing on jockey health and welfare, the organization announced Tuesday.
A New Mexico District Court judge has ruled that the New Mexico Racing Commission cannot deduct insurance premiums for jockeys and exercise riders from the subsidies that casinos in the state provide for purses at racetracks.
A division of 1/ST, the racing company that owns and operates Santa Anita Park and Gulfstream Park, has reached a deal with a major sports-betting company that will result in the launch of a new account-wagering service and various cross-promotions, the companies announced on Thursday.
Total betting on U.S. races in September was up 2.7 percent compared to the same month last year, despite a 4.8 percent decline in the number of races held, according to data released Wednesday by Equibase.
Dr. Michael Hardy, a former regulatory veterinarian who was recently appointed as the safety officer for Horseshoe Indianapolis, has been hired as the executive director of the Racing Medication and Testing Consortium, an industry funded medication and drug advisory organization.
A Texas congressman filed legislation on Tuesday that would delay the full-scale implementation of the Horseracing Integrity and Safety Authority until Jan. 1, 2024.
Dr. Mary Scollay, the executive director of the Racing Medication and Testing Consortium, has been named the chief science officer of a division of the Horseracing Integrity and Safety Authority, the organization announced on Tuesday.
